The Current and Emerging Actinic Keratosis Treatment Landscape

In this video interview, Ted Lain, MD, discusses the causes and effects of actinic keratosis, as well as the unmet needs, how to diagnose, and what treatments are currently available.

Related Videos
David Light, CEO of Valisure
sunscreen
Related Content

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

Oral Nicotinamide Not Beneficial in Preventing Skin Cancer in Organ Transplant Recipients

March 3rd 2023

The Cutaneous Connection: Episode 24- Benzene Found in Multiple Sunscreen Products

May 27th 2021

PROAK Study: Tirbanibulin Boosts Quality of Life for Patients With Actinic Keratosis

February 18th 2023

Tirbanibulin Improves Skin in Patients with Actinic Keratosis

February 12th 2023

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

Oral Nicotinamide Not Beneficial in Preventing Skin Cancer in Organ Transplant Recipients

March 3rd 2023

The Cutaneous Connection: Episode 24- Benzene Found in Multiple Sunscreen Products

May 27th 2021

PROAK Study: Tirbanibulin Boosts Quality of Life for Patients With Actinic Keratosis

February 18th 2023

Tirbanibulin Improves Skin in Patients with Actinic Keratosis

February 12th 2023

FDA Approves Retifanlimab-Dlwr for the Treatment of Metastatic or Recurrent Locally Advanced MCC

March 22nd 2023

The Cutaneous Connection: Episode 27- Benzene Contamination Update

July 22nd 2021

Oral Nicotinamide Not Beneficial in Preventing Skin Cancer in Organ Transplant Recipients

March 3rd 2023

The Cutaneous Connection: Episode 24- Benzene Found in Multiple Sunscreen Products

May 27th 2021

PROAK Study: Tirbanibulin Boosts Quality of Life for Patients With Actinic Keratosis

February 18th 2023

Tirbanibulin Improves Skin in Patients with Actinic Keratosis

February 12th 2023
© 2023 MJH Life Sciences

All rights reserved.